R. Johnsen

1.2k total citations
43 papers, 972 citations indexed

About

R. Johnsen is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, R. Johnsen has authored 43 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 12 papers in Physiology and 5 papers in Epidemiology. Recurrent topics in R. Johnsen's work include Muscle Physiology and Disorders (25 papers), RNA Research and Splicing (10 papers) and RNA Interference and Gene Delivery (9 papers). R. Johnsen is often cited by papers focused on Muscle Physiology and Disorders (25 papers), RNA Research and Splicing (10 papers) and RNA Interference and Gene Delivery (9 papers). R. Johnsen collaborates with scholars based in Australia, United States and United Kingdom. R. Johnsen's co-authors include Steve D. Wilton, Sue Fletcher, Byron A. Kakulas, Abbie Fall, Kaite Honeyman, Frank Mastaglia, John Mamo, Penny L Harding, Susan Galloway and Menuka M. Pallebage‐Gamarallage and has published in prestigious journals such as PLoS ONE, Brain and Scientific Reports.

In The Last Decade

R. Johnsen

43 papers receiving 948 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Johnsen Australia 17 657 264 181 132 117 43 972
Taku Nedachi Japan 20 849 1.3× 316 1.2× 67 0.4× 76 0.6× 41 0.4× 34 1.4k
Yasushi Maeda Japan 20 843 1.3× 116 0.4× 156 0.9× 304 2.3× 155 1.3× 58 1.3k
Hiroyuki Awano Japan 21 1.2k 1.8× 156 0.6× 191 1.1× 53 0.4× 320 2.7× 125 1.5k
Raffaella Di Lisi Italy 8 1.3k 1.9× 490 1.9× 73 0.4× 63 0.5× 72 0.6× 8 1.8k
Cody A. Desjardins United States 13 544 0.8× 69 0.3× 92 0.5× 108 0.8× 64 0.5× 14 759
Masahito Ogasawara Japan 16 412 0.6× 168 0.6× 37 0.2× 152 1.2× 97 0.8× 30 906
Darin Bloemberg Canada 17 826 1.3× 446 1.7× 59 0.3× 43 0.3× 61 0.5× 33 1.3k
Jun Tanihata Japan 17 700 1.1× 166 0.6× 112 0.6× 28 0.2× 89 0.8× 40 906

Countries citing papers authored by R. Johnsen

Since Specialization
Citations

This map shows the geographic impact of R. Johnsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Johnsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Johnsen more than expected).

Fields of papers citing papers by R. Johnsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Johnsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Johnsen. The network helps show where R. Johnsen may publish in the future.

Co-authorship network of co-authors of R. Johnsen

This figure shows the co-authorship network connecting the top 25 collaborators of R. Johnsen. A scholar is included among the top collaborators of R. Johnsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Johnsen. R. Johnsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnsen, R., Mark R. Davis, U. Moore, et al.. (2022). Identification of a novel heterozygous DYSF variant in a large family with a dominantly‐inherited dysferlinopathy. Neuropathology and Applied Neurobiology. 48(7). e12846–e12846. 8 indexed citations
2.
Li, Dunhui, A.M. Adams, R. Johnsen, Sue Fletcher, & Steve D. Wilton. (2020). Morpholino Oligomer-Induced Dystrophin Isoforms to Map the Functional Domains in the Dystrophin Protein. Molecular Therapy — Nucleic Acids. 22. 263–272. 10 indexed citations
3.
Johnsen, R., et al.. (2020). Single Exon Skipping Can Address a Multi-Exon Duplication in the Dystrophin Gene. International Journal of Molecular Sciences. 21(12). 4511–4511. 3 indexed citations
4.
Aung-Htut, May T., Michel Tchan, R. Johnsen, et al.. (2020). Splice modulating antisense oligonucleotides restore some acid-alpha-glucosidase activity in cells derived from patients with late-onset Pompe disease. Scientific Reports. 10(1). 6702–6702. 6 indexed citations
5.
Schnell, Frederick J., Diane E. Frank, Sue Fletcher, R. Johnsen, & Steve D. Wilton. (2019). Challenges of Interpreting Dystrophin Content by Western Blot. 15(1). 40–40. 7 indexed citations
6.
Aung-Htut, May T., et al.. (2019). Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides. Scientific Reports. 9(1). 12994–12994. 12 indexed citations
7.
Luo, Yue‐Bei, Chalermchai Mitrpant, A.M. Adams, et al.. (2014). Antisense Oligonucleotide Induction of Progerin in Human Myogenic Cells. PLoS ONE. 9(6). e98306–e98306. 10 indexed citations
8.
Fletcher, Sue, C. Adkin, Brenda Wong, et al.. (2012). Targeted Exon Skipping to Address “Leaky” Mutations in the Dystrophin Gene. Molecular Therapy — Nucleic Acids. 1. e48–e48. 17 indexed citations
9.
Adams, A.M., et al.. (2011). Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching. BMC Medical Genetics. 12(1). 141–141. 10 indexed citations
10.
Fletcher, Sue, et al.. (2010). Dystrophin Isoform Induction In Vivo by Antisense-mediated Alternative Splicing. Molecular Therapy. 18(6). 1218–1223. 20 indexed citations
11.
Takechi, Ryusuke, Susan Galloway, Menuka M. Pallebage‐Gamarallage, et al.. (2009). Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-β. British Journal Of Nutrition. 103(5). 652–662. 64 indexed citations
12.
Takechi, Ryusuke, Susan Galloway, Menuka M. Pallebage‐Gamarallage, R. Johnsen, & John Mamo. (2008). Three-dimensional immunofluorescent double labelling using polyclonal antibodies derived from the same species: enterocytic colocalization of chylomicrons with Golgi apparatus. Histochemistry and Cell Biology. 129(6). 779–784. 16 indexed citations
13.
Pallebage‐Gamarallage, Menuka M., Susan Galloway, R. Johnsen, et al.. (2008). The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-β abundance. British Journal Of Nutrition. 101(3). 340–347. 16 indexed citations
14.
Galloway, Susan, Menuka Pallebage‐Gamarallage, Ryusuke Takechi, et al.. (2008). Synergistic effects of high fat feeding and apolipoprotein E deletion on enterocytic amyloid-beta abundance. Lipids in Health and Disease. 7(1). 15–15. 20 indexed citations
15.
Mastaglia, Frank, R. Johnsen, & Byron A. Kakulas. (2002). Prevalence of stroke in Parkinson's disease: A postmortem study. Movement Disorders. 17(4). 772–774. 59 indexed citations
16.
Nowak, Kristen L., P. J. Walsh, R. Johnsen, et al.. (2000). Severe γ-sarcoglycanopathy caused by a novel missense mutation and a large deletion. Neuromuscular Disorders. 10(2). 100–107. 16 indexed citations
17.
Howell, J. McC., Sue Fletcher, Amanda J. O’Hara, et al.. (1998). Direct dystrophin and reporter gene transfer into dog muscle in vivo. Muscle & Nerve. 21(2). 159–165. 10 indexed citations
18.
Anderson, Judy E., et al.. (1993). Comparison of basic fibroblast growth factor in X-linked dystrophin-deficient myopathies of human, dog and mouse.. UWA Profiles and Research Repository (University of Western Australia). 9(2). 107–21. 30 indexed citations
19.
Wilton, Steve D., et al.. (1993). Two distinct mutations in a single dystrophin gene: Identification of an altered splice‐site as the primary becker muscular dystrophy mutation. American Journal of Medical Genetics. 46(5). 563–569. 33 indexed citations
20.
Johnsen, R.. (1964). Biochemistry. (Book Reviews: The Biosynthesis of Vitamins and Related Compounds). Scientia Forestalis. 146(3645). 760. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026